Clinical Trial Update: Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tislelizumab with bevacizumab and albumin paclitaxel in advanced lung adenocarcinoma (Stage IV) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Bevacizumab (bevacizumab)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Zhou Chengzhi | Conditions: Lung Adenocarcinoma Stage IV | Phase 2 | Status: COMPLETED